UroGen Pharma (URGN)
Q4 2018 Earnings Conference Call
February 28, 2019 8:30 A.M. ET
Company Participants
Kate Bechtold - Director, Corporate Communications and Investor Relations
Liz Barrett - President and Chief Executive Officer
Mark Schoenberg - Chief Medical Officer
Peter Pfreundschuh - Chief Financial Officer
Conference Call Participants
Ram Selvaraju - H. C. Wainwright
Boris Peaker - Cowen
Leland Gershell - Oppenheimer
Chris Howerton - Jefferies
Presentation
Operator
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to UroGen Pharma's Fourth Quarter and Full Year 2018 Financial Results and Business Update Conference